Literature DB >> 25451038

A dietary phytochemical blend prevents liver damage associated with adipose tissue mobilization in ovariectomized rats.

Colette N Miller1, Jeong-Yeh Yang, Tucker Avra, Suresh Ambati, Mary Anne Della-Fera, Srujana Rayalam, Clifton A Baile.   

Abstract

OBJECTIVE: Menopausal reduction in estrogen causes increased adipose accumulation, leading many to turn to dietary supplements to prevent and treat such changes. Enhanced adipose mobilization stimulated by some supplements can increase the risk of non-alcoholic fatty liver disease (NAFLD). Cytoprotective and anti-obesity compounds may prevent the lipotoxicity associated with mobilization.
METHODS: A phytochemical blend was tested in aged, ovariectomized rats. Rats were given the AIN-93M basal diet or a diet containing varying doses of phytochemicals with 2.4 IU/g vitamin D [diet 1: 1000 mg/kg genistein (G); diet 2: 500 mg/kg (G), 200 mg/kg resveratrol (R), and 1000 mg/kg quercetin (Q); diet 3: 1000 mg/kg (G), 400 mg/kg (R), and 2000 mg/kg (Q)].
RESULTS: Serum free fatty acids and hepatic triglycerides were elevated with diets 2 and 3. Despite this increase, the phytochemical blends did not increase apoptotic, cell repair, or remodeling gene expression. The highest phytochemical dose prevented increases in serum alanine aminotransferase.
CONCLUSIONS: Adverse hepatic effects secondary to ovariectomy were mitigated through the inclusion of a dietary phytochemical blend in aged ovariectomized rats. The use of such compounds may not only help with weight management and disease risk in menopausal women, but may also prevent the lipotoxicity in NAFLD.
© 2014 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25451038     DOI: 10.1002/oby.20907

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  3 in total

Review 1.  Endocrine disrupting chemicals: Friend or foe to brown and beige adipose tissue?

Authors:  Cynthia E Francis; Logan Allee; Helen Nguyen; Rachel D Grindstaff; Colette N Miller; Srujana Rayalam
Journal:  Toxicology       Date:  2021-10-02       Impact factor: 4.571

2.  Protective Effects and Mechanism of Meretrix meretrix Oligopeptides against Nonalcoholic Fatty Liver Disease.

Authors:  Fangfang Huang; Shasha Zhao; Fangmiao Yu; Zuisu Yang; Guofang Ding
Journal:  Mar Drugs       Date:  2017-02-14       Impact factor: 5.118

3.  Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis.

Authors:  Jinwang Li; Siyu Xie; Wendi Teng
Journal:  Nutrients       Date:  2021-12-24       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.